These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 15296956)
61. Advanced topical formulations (ATF). Hadgraft J; Lane ME Int J Pharm; 2016 Nov; 514(1):52-57. PubMed ID: 27260130 [TBL] [Abstract][Full Text] [Related]
62. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin. Choi A; Gang H; Chun I; Gwak H Int J Pharm; 2008 Jun; 357(1-2):126-31. PubMed ID: 18329198 [TBL] [Abstract][Full Text] [Related]
63. Physicochemical interpretation of the pharmacokinetics of percutaneous absorption. Guy RH; Hadgraft J J Pharmacokinet Biopharm; 1983 Apr; 11(2):189-203. PubMed ID: 6886974 [TBL] [Abstract][Full Text] [Related]
64. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010 [TBL] [Abstract][Full Text] [Related]
65. The application of molecular structural predictors of intestinal absorption to screening of compounds for transdermal penetration. Grice JE; Cross SE; Brownlie C; Roberts MS J Pharm Pharmacol; 2010 Jun; 62(6):750-5. PubMed ID: 20636862 [TBL] [Abstract][Full Text] [Related]
66. Recent developments in topical and transdermal delivery. Hadgraft J Eur J Drug Metab Pharmacokinet; 1996; 21(2):165-73. PubMed ID: 8839691 [TBL] [Abstract][Full Text] [Related]
67. Virtual design of chemical penetration enhancers for transdermal drug delivery. Golla S; Neely BJ; Whitebay E; Madihally S; Robinson RL; Gasem KA Chem Biol Drug Des; 2012 Apr; 79(4):478-87. PubMed ID: 22172168 [TBL] [Abstract][Full Text] [Related]
68. Permeability of the skin. Scheuplein RJ; Blank IH Physiol Rev; 1971 Oct; 51(4):702-47. PubMed ID: 4940637 [No Abstract] [Full Text] [Related]
70. Computer Simulation of Skin Permeability of Hydrophobic and Hydrophilic Chemicals - Influence of Follicular Pathway. Yu F; Tonnis K; Kasting GB; Jaworska J J Pharm Sci; 2021 May; 110(5):2149-2156. PubMed ID: 33359309 [TBL] [Abstract][Full Text] [Related]
71. Pharmacokinetics of drug permeation through human skin. Chandrasekaran SK; Bayne W; Shaw JE J Pharm Sci; 1978 Oct; 67(10):1370-4. PubMed ID: 702282 [TBL] [Abstract][Full Text] [Related]
72. An investigation of the mechanism of flux across polydimethylsiloxane membranes by use of quantitative structure-permeability relationships. Cronin MT; Dearden JC; Gupta R; Moss GP J Pharm Pharmacol; 1998 Feb; 50(2):143-52. PubMed ID: 9530981 [TBL] [Abstract][Full Text] [Related]
73. Design of chemical structure for optimal dermal delivery. Higuchi T Curr Probl Dermatol; 1978; 7():121-31. PubMed ID: 752448 [TBL] [Abstract][Full Text] [Related]
74. This issue at a glance: skin reactions of astronauts in space and microstructures of topically applied formulations. Lademann J; Fluhr J Skin Pharmacol Physiol; 2008; 21(5):245. PubMed ID: 18997481 [No Abstract] [Full Text] [Related]
75. Modeling percutaneous absorption for successful drug discovery and development. Cheruvu HS; Liu X; Grice JE; Roberts MS Expert Opin Drug Discov; 2020 Oct; 15(10):1181-1198. PubMed ID: 32584615 [TBL] [Abstract][Full Text] [Related]
76. Percutaneous absorption and age. Implications for therapy. Roskos KV; Maibach HI Drugs Aging; 1992; 2(5):432-49. PubMed ID: 1392224 [TBL] [Abstract][Full Text] [Related]